FindTrial
Sign In

Preoperative Plasma ctDNA Levels Predicting Recurrence After Resection of Hepatocellular Carcinoma: A Retrospective Study

Preoperative Plasma ctDNA Levels Predicting Recurrence After Resection of Hepatocellular Carcinoma: A Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111131
Enrollment
Unknown
Registered
2025-10-27
Start date
2025-10-30
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

Observation Group of Hepatocellular carcinoma:None

Sponsors

Affiliated Hospital of Guangdong Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.There was no distant metastasis before the operation, and the postoperative pathological diagnosis was hepatocellular carcinoma. 2. Age >=18 years old; 3. Undergo radical resection and have plasma samples retained before the operation; 4. Have complete clinical data, including imaging, laboratory tests and follow-up data;

Exclusion criteria

Exclusion criteria: 1.Presence of other malignancies; 2.Incomplete data or insufficient follow-up; 3.Insufficient plasma sample volume or inability to perform ctDNA testing;

Design outcomes

Primary

MeasureTime frame
Preoperative plasma ctDNA content;Serum tumor markers;—

Countries

China

Contacts

Public ContactXu Hao

Affiliated Hospital of Guangdong Medical University

776730533@qq.com+86 759 238 7417

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026